NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

NCT06331520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

644

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting
Highly Emetogenic Chemotherapy

Interventions

DRUG: Netupitant / Palonosetron Oral Capsule [Akynzeo]
DRUG: Olanzapine
DRUG: Dexamethasone Oral

Sponsor

Fudan University